Publication | Closed Access

Impact of PCSK9 inhibition on coronary atheroma progression: Rationale and design of Global Assessment of Plaque Regression with a PCSK9 Antibody as Measured by Intravascular Ultrasound (GLAGOV)

Cardiovascular Translational ResearchCardiovascular DiseasePcsk9 InhibitionImmunologyPathologyPcsk9 AntibodyVascular BiologyPlaque RegressionPublic HealthMedicineAtherosclerosisCoronary Artery DiseaseCoronary Heart DiseaseCardiovascular Imaging